Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Sell
45
CCLD Quote, Financials, Valuation and Earnings
Last price:
$2.14
Seasonality move
:
22.07%
Day range:
$1.73 - $1.89
52-week range:
$1.04 - $4.84
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.25x
P/B ratio:
1.49x
Volume:
358.4K
Avg. volume:
512.2K
1-year change:
60.55%
Market cap:
$74.1M
Revenue:
$110.8M
EPS (TTM):
-$0.20
Analysts' Opinion
-
Consensus RatingCareCloud has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.43, CareCloud has an estimated upside of 152.86% from its current price of $1.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.50 representing 14.29% downside risk from its current price of $1.75.
Fair Value
-
According to the consensus of 2 analysts, CareCloud has 152.86% upside to fair value with a price target of $4.43 per share.
CCLD vs. S&P 500
-
Over the past 5 trading days, CareCloud has underperformed the S&P 500 by -4.18% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CareCloud does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CareCloud revenues have been falling on a year-over-year basis for 10 quarters in a row. In the most recent quarter CareCloud reported revenues of $28.2M.
Earnings Growth
-
CareCloud has grown year-over-year earnings for 0 quarters straight. In the most recent quarter CareCloud reported earnings per share of --.
Enterprise value:
69.3M
EV / Invested capital:
--
Price / LTM sales:
0.25x
EV / EBIT:
7.77x
EV / Revenue:
0.62x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
5.23x
Price / Operating cash flow:
2.13x
Enterprise value / EBITDA:
2.73x
Gross Profit (TTM):
$50M
Return On Assets:
10.58%
Net Income Margin (TTM):
7.08%
Return On Equity:
17.63%
Return On Invested Capital:
15.82%
Operating Margin:
12.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $138.8M | $117.1M | $110.8M | $28.4M | $28.2M | |
| Gross Profit | $54.4M | $46.2M | $50M | $11.4M | $13.2M | |
| Operating Income | $4.7M | -$4M | $9.7M | -$958K | $3.5M | |
| EBITDA | $21.6M | -$30.8M | $25.4M | -$37.5M | $8.7M | |
| Diluted EPS | -$0.66 | -$4.11 | -$0.20 | -$3.04 | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $44.8M | $35.6M | $34.7M | $23.2M | $24.8M | |
| Total Assets | $138M | $140.8M | $136.2M | $77.8M | $71.6M | |
| Current Liabilities | $29M | $29.6M | $22.4M | $23.3M | $19.6M | |
| Total Liabilities | $36.8M | $42.9M | $34.5M | $36.1M | $21.8M | |
| Total Equity | $101.2M | $97.9M | $101.7M | $41.7M | $49.8M | |
| Total Debt | $442K | $8.4M | $8.3M | $10.3M | $336K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $21.2M | $15.5M | $20.6M | $3.7M | $5.2M | |
| Cash From Investing | -$11.8M | -$11.6M | -$7.4M | -$2.3M | -$2.3M | |
| Cash From Financing | -$7.7M | -$13.3M | -$11.3M | -$4.9M | -$578K | |
| Free Cash Flow | $9.4M | $3.8M | $13.2M | $1.4M | $3M | |
CCLD
Sector
Market Cap
$74.1M
$35.1M
Price % of 52-Week High
36.16%
44.56%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
60.55%
-40.62%
Beta (5-Year)
2.047
0.662
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.78
200-day SMA
Sell
Level
$2.65
Bollinger Bands (100)
Sell
Level
1.65 - 3.79
Chaikin Money Flow
Sell
Level
-75.3M
20-day SMA
Buy
Level
$1.52
Relative Strength Index (RSI14)
Buy
Level
53.72
ADX Line
Buy
Level
22.76
Williams %R
Neutral
Level
-33.3434
50-day SMA
Sell
Level
$1.80
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
226.6M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3779)
Buy
CA Score
(Annual)
Level (1.1708)
Buy
Beneish M-Score
(Annual)
Level (-3.1779)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-5.535)
Buy
Piotroski F Score
(Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Stock Forecast FAQ
In the current month, CCLD has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CCLD average analyst price target in the past 3 months is $4.43.
-
Where Will CareCloud Stock Be In 1 Year?
According to analysts, the consensus estimate is that CareCloud share price will rise to $4.43 per share over the next 12 months.
-
What Do Analysts Say About CareCloud?
Analysts are divided on their view about CareCloud share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CareCloud is a Sell and believe this share price will drop from its current level to $1.50.
-
What Is CareCloud's Price Target?
The price target for CareCloud over the next 1-year time period is forecast to be $4.43 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CCLD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CareCloud is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CCLD?
You can purchase shares of CareCloud via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CareCloud shares.
-
What Is The CareCloud Share Price Today?
CareCloud was last trading at $2.14 per share. This represents the most recent stock quote for CareCloud. Yesterday, CareCloud closed at $1.75 per share.
-
How To Buy CareCloud Stock Online?
In order to purchase CareCloud stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.07% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 11% over the past day.
